Bovie Medical Corporation (NYSEMKT:BVX) Reports Decline in Sellers; Strong Momentum for Longs

June 19, 2017 - By Adrian Mccoy

 Bovie Medical Corporation (NYSEMKT:BVX) Reports Decline in Sellers; Strong Momentum for Longs

Investors sentiment decreased to 1.53 in 2016 Q4. Its down 0.91, from 2.44 in 2016Q3. It fall, as 9 investors sold Bovie Medical Corporation shares while 6 reduced holdings. 11 funds opened positions while 12 raised stakes. 9.00 million shares or 42.24% more from 6.33 million shares in 2016Q3 were reported.
Blackrock Fund Advsr holds 0% or 75,721 shares. Thompson Davis Inc holds 0.01% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX) for 2,000 shares. Blackrock Institutional Tru Na has invested 0% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX). Dimensional Fund Advsrs Limited Partnership invested in 252,308 shares. Kcg Holdg holds 0% or 33,527 shares. Citadel Ltd Liability owns 11,951 shares. Deutsche Commercial Bank Ag reported 5,428 shares stake. Bank Of America Corporation De owns 1 shares for 0% of their portfolio. 88,338 are held by Northern. Creative Planning holds 1,475 shares. Commonwealth Equity Services holds 0% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX) for 10,700 shares. Renaissance Technology Ltd Liability Company holds 0% or 330,800 shares in its portfolio. Oberweis Asset Management holds 65,000 shares. Blackrock Lc invested in 0% or 4,719 shares. Vanguard has 812,956 shares.

The stock of Bovie Medical Corporation (NYSEMKT:BVX) registered a decrease of 15.68% in short interest. BVX’s total short interest was 118,300 shares in June as published by FINRA. Its down 15.68% from 140,300 shares, reported previously. With 61,800 shares average volume, it will take short sellers 2 days to cover their BVX’s short positions. The short interest to Bovie Medical Corporation’s float is 0.51%.

About 4,188 shares traded. Bovie Medical Corporation (NYSEMKT:BVX) has risen 28.74% since June 19, 2016 and is uptrending. It has outperformed by 12.04% the S&P500.

Bovie Medical Corporation is an energy medical device company. The company has market cap of $69.11 million. The Firm is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It currently has negative earnings. It operates through three divisions: Core, OEM and J-Plasma.

More notable recent Bovie Medical Corporation (NYSEMKT:BVX) news were published by: Seekingalpha.com which released: “Bovie Medical’s Turnaround Is Here” on March 01, 2016, also Seekingalpha.com with their article: “Bovie Medical Corporation’s (BVX) CEO Rob Gershon on Q4 2016 Results …” published on March 10, 2017, Seekingalpha.com published: “Bovie Medical: Buy The Business, Get A Multi-Billion Dollar Product Pipeline Free” on March 24, 2014. More interesting news about Bovie Medical Corporation (NYSEMKT:BVX) were released by: Seekingalpha.com and their article: “Bovie Medical: Little Bovie May Be Running With The Big Dogs” published on July 22, 2014 as well as Reuters.com‘s news article titled: “BRIEF-Bovie Medical Corp reports Q1 loss per share $0.06” with publication date: May 15, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.